PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF

PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF was reported 4830 times

PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MODIFIED RADICAL MASTECTOMY 19 0.3276
1 AXILLARY LYMPHADENECTOMY 16 0.2051
2 ACUTE NECROTISING ENCEPHALOPATHY 1 0.1667
3 POLYNEUROPATHY CHRONIC 7 0.1029
4 HORMONE RECEPTOR NEGATIVE HER2 POSITIVE BREAST CANCER 1 0.0909
5 HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR POSITIVE 1 0.0833
6 INCISION SITE DISCOMFORT 1 0.0714
7 ADMINISTRATION SITE REACTION 26 0.0674
8 DIABETIC DERMOPATHY 1 0.0625
9 BREAST OPERATION 34 0.0416
10 IMMUNE-MEDIATED MYELITIS 1 0.0385
11 ADMINISTRATION SITE PAIN 42 0.0364
12 GINGIVAL HYPERPIGMENTATION 1 0.0323
13 BREAST CONSERVING SURGERY 16 0.0312
14 BIOPSY LYMPH GLAND 3 0.0306
15 INFECTED SEROMA 2 0.0278
16 ADMINISTRATION SITE HAEMATOMA 1 0.0250
17 ADMINISTRATION SITE SWELLING 8 0.0246
18 ADMINISTRATION SITE ERYTHEMA 7 0.0246
19 ADMINISTRATION SITE OEDEMA 2 0.0233
20 MASTECTOMY 37 0.0211
21 FUNGAL RHINITIS 2 0.0187
22 SPLENIC GRANULOMA 2 0.0187
23 INTERCEPTED PRODUCT STORAGE ERROR 50 0.0140
24 DRAIN REMOVAL 1 0.0135
25 AXILLARY VEIN THROMBOSIS 5 0.0135
26 ACTINIC ELASTOSIS 1 0.0132
27 CANCER FATIGUE 3 0.0126
28 BREAST PROSTHESIS REMOVAL 1 0.0123
29 BREAST INJURY 2 0.0123
30 CELLULITE 4 0.0123
31 ADMINISTRATION SITE WARMTH 1 0.0122
32 HYPERALBUMINAEMIA 1 0.0122
33 HER2 POSITIVE BREAST CANCER 4 0.0107
34 ADMINISTRATION SITE DISCOMFORT 2 0.0106
35 DEFICIENCY ANAEMIA 1 0.0105
36 ANAL RASH 1 0.0104
37 METASTATIC LYMPHOMA 4 0.0102
38 COMPUTERISED TOMOGRAM HEAD ABNORMAL 1 0.0101
39 INVASIVE BREAST CARCINOMA 4 0.0097
40 HEART FAILURE WITH REDUCED EJECTION FRACTION 5 0.0093
41 INCISION SITE CELLULITIS 1 0.0093
42 BREAST NEOPLASM 9 0.0087
43 RENAL-LIMITED THROMBOTIC MICROANGIOPATHY 2 0.0087
44 NASAL ABSCESS 2 0.0087
45 TUMOUR ULCERATION 2 0.0084
46 COPPER DEFICIENCY 1 0.0083
47 DILATED CARDIOMYOPATHY 8 0.0079
48 ADMINISTRATION SITE RASH 1 0.0078
49 HEPATOPULMONARY SYNDROME 1 0.0070
50 ENDOMETRIAL ATROPHY 1 0.0069
51 BREAST DISCOLOURATION 1 0.0063
52 NODULAR REGENERATIVE HYPERPLASIA 4 0.0062
53 BREAST HAEMORRHAGE 2 0.0061
54 PSEUDOCIRRHOSIS 2 0.0060
55 BONE CANCER METASTATIC 3 0.0057
56 SCAN ABNORMAL 2 0.0054
57 LOCAL REACTION 4 0.0054
58 COMPUTERISED TOMOGRAM ABDOMEN ABNORMAL 1 0.0052
59 ADMINISTRATION RELATED REACTION 1 0.0051
60 LYMPHADENECTOMY 5 0.0051
61 CONVULSIONS LOCAL 1 0.0051
62 NO ADVERSE EVENT 912 0.0050
63 HERPES DERMATITIS 1 0.0050
64 ADENOCARCINOMA METASTATIC 1 0.0049
65 COLONY STIMULATING FACTOR THERAPY 1 0.0048
66 ATRIOVENTRICULAR DISSOCIATION 1 0.0047
67 ALANINE AMINOTRANSFERASE 1 0.0045
68 METASTASES TO CENTRAL NERVOUS SYSTEM 58 0.0045
69 DIFFUSE ALVEOLAR DAMAGE 5 0.0043
70 TUMOUR INVASION 2 0.0041
71 CARDIAC DYSFUNCTION 15 0.0040
72 ONYCHALGIA 4 0.0040
73 DRAIN PLACEMENT 1 0.0039
74 VERTEBRAL LESION 2 0.0039
75 METASTASES TO SKIN 4 0.0039
76 ORTHOPAEDIC PROCEDURE 2 0.0039
77 INCISION SITE ABSCESS 1 0.0038
78 HYPERHOMOCYSTEINAEMIA 1 0.0038
79 DIARRHOEA INFECTIOUS 3 0.0038
80 EPIRETINAL MEMBRANE 1 0.0036
81 BREAST DISORDER 7 0.0034
82 IMPLANT SITE INFLAMMATION 1 0.0034
83 CARDIAC FUNCTION TEST ABNORMAL 1 0.0034
84 INVASIVE DUCTAL BREAST CARCINOMA 9 0.0033
85 TERMINAL ILEITIS 2 0.0033
86 BIOPSY BREAST 1 0.0032
87 RECURRENT CANCER 13 0.0032
88 BREAST CANCER RECURRENT 10 0.0032
89 PERIORAL DERMATITIS 2 0.0031
90 ECHOLALIA 1 0.0031
91 APPLICATION SITE OEDEMA 1 0.0031
92 INJECTION SITE HYPERTROPHY 1 0.0031
93 AORTITIS 2 0.0029
94 ADMINISTRATION SITE BRUISE 1 0.0029
95 EJECTION FRACTION DECREASED 44 0.0028
96 INVESTIGATION ABNORMAL 4 0.0028
97 METASTATIC NEOPLASM 12 0.0028
98 CEREBRAL MASS EFFECT 1 0.0028
99 BIOPSY LUNG 1 0.0027
100 CAPILLARY DISORDER 1 0.0026
101 RADIATION SKIN INJURY 3 0.0026
102 LICHEN PLANUS 6 0.0026
103 THERAPEUTIC PRODUCT EFFECT INCREASED 3 0.0026
104 ADRENAL GLAND CANCER 1 0.0026
105 NAIL DISCOLOURATION 10 0.0025
106 HUMAN PAPILLOMA VIRUS TEST POSITIVE 1 0.0025
107 ACOUSTIC NEUROMA 1 0.0024
108 INJECTION SITE REACTION 162 0.0024
109 VITAL FUNCTIONS ABNORMAL 2 0.0023
110 HEPATIC CANCER METASTATIC 2 0.0023
111 CATATONIA 12 0.0023
112 GINGIVAL BLISTER 1 0.0023
113 PHARYNGEAL ULCERATION 3 0.0023
114 BREAST MASS 15 0.0022
115 PRURIGO 2 0.0022
116 CANCER SURGERY 2 0.0021
117 FAECAL VOLUME DECREASED 1 0.0021
118 DRAINAGE 1 0.0020
119 DERMATITIS INFECTED 1 0.0020
120 PRODUCT TEMPERATURE EXCURSION ISSUE 10 0.0019
121 VENOUS THROMBOSIS LIMB 4 0.0019
122 OSTEOSCLEROSIS 3 0.0019
123 OPTIC NEUROPATHY 4 0.0019
124 RADIATION INJURY 2 0.0019
125 INADEQUATE DIET 1 0.0019
126 GINGIVAL DISCOLOURATION 1 0.0019
127 EOSINOPHIL PERCENTAGE INCREASED 1 0.0018
128 TUMOUR PSEUDOPROGRESSION 2 0.0018
129 INJECTION RELATED REACTION 3 0.0018
130 ARTHROPOD STING 3 0.0018
131 HELICOBACTER TEST POSITIVE 1 0.0018
132 METASTASES TO SPINE 6 0.0018
133 CENTRAL NERVOUS SYSTEM INFECTION 2 0.0017
134 PALMAR ERYTHEMA 2 0.0017
135 OPTIC NERVE INJURY 2 0.0017
136 EJECTION FRACTION 1 0.0017
137 FEBRILE INFECTION 2 0.0017
138 DRUG MONITORING PROCEDURE NOT PERFORMED 3 0.0017
139 PRODUCT PACKAGING CONFUSION 4 0.0016
140 METASTASES TO BONE 27 0.0016
141 XEROSIS 2 0.0016
142 INTRADUCTAL PROLIFERATIVE BREAST LESION 2 0.0016
143 AORTIC VALVE REPLACEMENT 2 0.0016
144 SEROMA 2 0.0016
145 HEPATIC INFECTION 2 0.0016
146 LYMPHADENOPATHY MEDIASTINAL 3 0.0016
147 BLOOD PRESSURE MEASUREMENT 1 0.0016
148 ENTEROCOCCUS TEST POSITIVE 1 0.0015
149 HYPERAEMIA 3 0.0015
150 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 1 0.0015
151 GENE MUTATION 3 0.0015
152 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 1 0.0015
153 EMBOLIC CEREBRAL INFARCTION 1 0.0015
154 CARDIAC DISCOMFORT 3 0.0015
155 HEAT ILLNESS 1 0.0015
156 CYTOKINE STORM 1 0.0015
157 ABSCESS ORAL 2 0.0015
158 JOINT INSTABILITY 2 0.0014
159 ECHOCARDIOGRAM ABNORMAL 2 0.0014
160 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 24 0.0014
161 BREAST CANCER METASTATIC 15 0.0014
162 NAIL INFECTION 2 0.0014
163 BLISTER RUPTURE 1 0.0013
164 CREATININE RENAL CLEARANCE INCREASED 1 0.0013
165 ESCHERICHIA INFECTION 11 0.0013
166 DENGUE FEVER 3 0.0013
167 ONYCHOCLASIS 9 0.0013
168 ORAL MUCOSAL ERUPTION 2 0.0013
169 INTERCEPTED MEDICATION ERROR 6 0.0013
170 NAIL DISORDER 11 0.0013
171 HYPOVOLAEMIC SHOCK 6 0.0013
172 HEPATITIS VIRAL 1 0.0012
173 SURGERY 73 0.0012
174 VULVOVAGINAL DRYNESS 4 0.0012
175 HAEMATOLOGICAL INFECTION 3 0.0012
176 DISEASE PROGRESSION 142 0.0012
177 AMAUROSIS 1 0.0012
178 METASTASES TO LYMPH NODES 8 0.0012
179 LOWER RESPIRATORY TRACT CONGESTION 2 0.0012
180 LAZINESS 2 0.0012
181 POLYNEUROPATHY 14 0.0012
182 VENTRICULAR DYSFUNCTION 3 0.0012
183 LUNG OPACITY 3 0.0011
184 ABDOMINAL SEPSIS 1 0.0011
185 FULL BLOOD COUNT ABNORMAL 12 0.0011
186 HAEMORRHAGE SUBCUTANEOUS 4 0.0011
187 ABDOMINAL NEOPLASM 1 0.0011
188 BREAST SWELLING 3 0.0011
189 VOCAL CORD PARALYSIS 2 0.0011
190 UTERINE POLYP 2 0.0011
191 ANAEMIA OF CHRONIC DISEASE 1 0.0011
192 INJECTION SITE DRYNESS 1 0.0011
193 METASTASES TO LIVER 19 0.0011
194 DYSENTERY 2 0.0011
195 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
196 HYPERMETROPIA 1 0.0011
197 CEREBRAL PALSY 1 0.0011
198 DRUG DISPENSED TO WRONG PATIENT 1 0.0010
199 GASTRIC INFECTION 4 0.0010
200 DISCOLOURED VOMIT 1 0.0010
201 TRAUMATIC LUNG INJURY 2 0.0010
202 OPTIC ISCHAEMIC NEUROPATHY 4 0.0010
203 OFF LABEL USE 902 0.0010
204 APPLICATION SITE BRUISE 1 0.0010
205 DRUG ADMINISTERED IN WRONG DEVICE 1 0.0010
206 HYPOGEUSIA 2 0.0010
207 DUODENAL PERFORATION 1 0.0010
208 UNDERWEIGHT 2 0.0010
209 LYMPHOEDEMA 7 0.0010
210 CARDIOTOXICITY 9 0.0010
211 IMMUNODEFICIENCY 15 0.0010
212 AGEUSIA 25 0.0010
213 MYELOSUPPRESSION 36 0.0010
214 HAEMANGIOMA OF LIVER 1 0.0010
215 METASTASIS 7 0.0010
216 BREAST ABSCESS 1 0.0010
217 AXILLARY MASS 1 0.0010
218 NEOPLASM 11 0.0010
219 METASTASES TO LUNG 11 0.0010
220 MOUTH ULCERATION 20 0.0009
221 VENTRICULAR HYPOKINESIA 3 0.0009
222 BONE NEOPLASM 1 0.0009
223 LEFT VENTRICULAR DYSFUNCTION 6 0.0009
224 CALCINOSIS 2 0.0009
225 IRON DEFICIENCY 4 0.0009
226 HYPERSENSITIVITY PNEUMONITIS 1 0.0009
227 BLOOD FIBRINOGEN DECREASED 1 0.0009
228 MENOPAUSAL SYMPTOMS 2 0.0009
229 DISCOURAGEMENT 2 0.0009
230 PERIPHERAL SENSORY NEUROPATHY 5 0.0009
231 THERMAL BURN 6 0.0008
232 PUSTULE 2 0.0008
233 MYOPIA 2 0.0008
234 VARICELLA 2 0.0008
235 WRONG DOSE 2 0.0008
236 EJECTION FRACTION ABNORMAL 1 0.0008
237 CENTRAL NERVOUS SYSTEM LESION 11 0.0008
238 MATERNAL EXPOSURE TIMING UNSPECIFIED 3 0.0008
239 PRODUCT PRESCRIBING ERROR 19 0.0008
240 PRODUCT ADMINISTRATION ERROR 16 0.0008
241 BRONCHIAL SECRETION RETENTION 1 0.0008
242 HEPATIC CYTOLYSIS 10 0.0008
243 ENTERITIS 5 0.0008
244 ENDOCRINE DISORDER 1 0.0008
245 ABDOMINAL OPERATION 1 0.0008
246 MUCOSAL INFLAMMATION 20 0.0008
247 NEUROPATHY PERIPHERAL 72 0.0008
248 CARDIAC FAILURE ACUTE 5 0.0007
249 ANION GAP INCREASED 1 0.0007
250 WEIGHT BEARING DIFFICULTY 2 0.0007
251 BODY MASS INDEX INCREASED 1 0.0007
252 EFFUSION 1 0.0007
253 CORNEAL ABRASION 1 0.0007
254 RHINALGIA 2 0.0007
255 HYPERTRANSAMINASAEMIA 5 0.0007
256 THROMBOTIC MICROANGIOPATHY 7 0.0007
257 SKIN REACTION 10 0.0007
258 GLOMERULAR FILTRATION RATE ABNORMAL 1 0.0007
259 FEBRILE BONE MARROW APLASIA 3 0.0007
260 ABSCESS LIMB 3 0.0007
261 TUMOUR HAEMORRHAGE 2 0.0007
262 GENITAL RASH 1 0.0007
263 INJECTION SITE HYPOAESTHESIA 1 0.0007
264 HEART VALVE INCOMPETENCE 2 0.0007
265 INJECTION SITE PAIN 213 0.0007
266 LUNG CANCER METASTATIC 2 0.0007
267 VITAMIN B12 DECREASED 2 0.0007
268 ENTEROCOLITIS 4 0.0007
269 TASTE DISORDER 14 0.0007
270 INTERSTITIAL LUNG DISEASE 33 0.0007
271 ANGIOPLASTY 1 0.0007
272 DIARRHOEA 432 0.0007
273 VASCULAR DEVICE INFECTION 3 0.0007
274 GAIT INABILITY 22 0.0007
275 DERMATITIS ACNEIFORM 4 0.0007
276 DYSCHEZIA 2 0.0007
277 LYMPHADENOPATHY 23 0.0006
278 CONCOMITANT DISEASE AGGRAVATED 4 0.0006
279 HYPERTROPHIC CARDIOMYOPATHY 1 0.0006
280 EYE ALLERGY 1 0.0006
281 PERFORMANCE STATUS DECREASED 3 0.0006
282 ELECTROCARDIOGRAM T WAVE ABNORMAL 1 0.0006
283 FLANK PAIN 6 0.0006
284 BLOOD CREATININE DECREASED 2 0.0006
285 BRAIN FOG 10 0.0006
286 COLITIS MICROSCOPIC 3 0.0006
287 GASTROINTESTINAL TOXICITY 3 0.0006
288 LOOSE TOOTH 2 0.0006
289 ILL-DEFINED DISORDER 37 0.0006
290 CARDIOMYOPATHY 9 0.0006
291 ANXIETY DISORDER 2 0.0006
292 NEOPLASM RECURRENCE 2 0.0006
293 PNEUMONITIS 16 0.0006
294 BLADDER NEOPLASM 1 0.0006
295 INJECTION SITE OEDEMA 1 0.0006
296 INFUSION RELATED REACTION 38 0.0006
297 BREAST DISCHARGE 1 0.0006
298 THROMBOPHLEBITIS 2 0.0006
299 INJECTION SITE DISCOMFORT 6 0.0006
300 PNEUMOTHORAX 9 0.0006
301 PULMONARY TOXICITY 4 0.0006
302 BREAST CYST 1 0.0006
303 BREAST PAIN 6 0.0006
304 INDURATION 1 0.0006
305 INJECTION SITE DISCHARGE 3 0.0006
306 BONE LESION 2 0.0006
307 ESSENTIAL HYPERTENSION 1 0.0005
308 FOOD INTOLERANCE 2 0.0005
309 FEEDING DISORDER 11 0.0005
310 GRANULOCYTE COUNT DECREASED 1 0.0005
311 CATHETER PLACEMENT 1 0.0005
312 BLOOD IRON INCREASED 1 0.0005
313 SKIN TOXICITY 3 0.0005
314 HEPATIC MASS 1 0.0005
315 APHTHOUS ULCER 4 0.0005
316 ORAL INFECTION 2 0.0005
317 VIRAL INFECTION 17 0.0005
318 HYPERCHLORHYDRIA 3 0.0005
319 FURUNCLE 4 0.0005
320 ULCER 8 0.0005
321 GANGRENE 3 0.0005
322 VITAMIN B12 DEFICIENCY 2 0.0005
323 PRODUCT STORAGE ERROR 43 0.0005
324 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 9 0.0005
325 RED CELL DISTRIBUTION WIDTH INCREASED 2 0.0005
326 NASAL DRYNESS 3 0.0005
327 FOLLICULITIS 5 0.0005
328 ONYCHOMADESIS 2 0.0005
329 RENAL PAIN 5 0.0005
330 HEPATIC LESION 2 0.0005
331 STOMATITIS 28 0.0005
332 PRODUCT DISPENSING ERROR 10 0.0005
333 IMMOBILE 2 0.0005
334 TONGUE DISCOLOURATION 2 0.0005
335 PYREXIA 157 0.0005
336 CLOSTRIDIUM TEST POSITIVE 1 0.0005
337 PHYSICAL DISABILITY 2 0.0005
338 COLITIS 17 0.0004
339 BRAIN NEOPLASM MALIGNANT 2 0.0004
340 IDIOPATHIC INTRACRANIAL HYPERTENSION 1 0.0004
341 POSTOPERATIVE WOUND INFECTION 3 0.0004
342 LEUKOCYTOSIS 8 0.0004
343 OPTIC NEURITIS 4 0.0004
344 HAEMOGLOBIN DECREASED 45 0.0004
345 BRAIN OPERATION 1 0.0004
346 METABOLIC ACIDOSIS 14 0.0004
347 NEPHROTIC SYNDROME 3 0.0004
348 BRAIN NEOPLASM 4 0.0004
349 ERYTHEMA 89 0.0004
350 RENAL FUNCTION TEST ABNORMAL 2 0.0004
351 HYPOPHAGIA 11 0.0004
352 MASS 6 0.0004
353 BILIRUBIN CONJUGATED INCREASED 1 0.0004
354 APPLICATION SITE REACTION 3 0.0004
355 SARCOIDOSIS 2 0.0004
356 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
357 CARDIOMEGALY 5 0.0004
358 CEREBRAL DISORDER 3 0.0004
359 ORGANISING PNEUMONIA 2 0.0004
360 PHARYNGITIS 5 0.0004
361 NEOPLASM PROGRESSION 14 0.0004
362 INFREQUENT BOWEL MOVEMENTS 1 0.0004
363 HYPOAESTHESIA 60 0.0004
364 INJECTION SITE DISCOLOURATION 5 0.0004
365 EYELID IRRITATION 1 0.0004
366 PNEUMOCYSTIS JIROVECII PNEUMONIA 4 0.0004
367 PEMPHIGOID 3 0.0004
368 KLEBSIELLA INFECTION 2 0.0004
369 PHLEBITIS 2 0.0004
370 NEOPLASM MALIGNANT 26 0.0004
371 BLOOD CHLORIDE DECREASED 1 0.0004
372 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 3 0.0004
373 HYPOALBUMINAEMIA 3 0.0004
374 MALABSORPTION 2 0.0004
375 TRICUSPID VALVE INCOMPETENCE 3 0.0004
376 CLOSTRIDIUM DIFFICILE COLITIS 4 0.0004
377 MYALGIA 63 0.0004
378 WHITE BLOOD CELL COUNT DECREASED 40 0.0004
379 GASTRIC PERFORATION 1 0.0004
380 PLATELET COUNT DECREASED 39 0.0004
381 BLOOD POTASSIUM DECREASED 11 0.0004
382 ASTHENIA 137 0.0004
383 ORAL DISCOMFORT 5 0.0004
384 NERVE INJURY 4 0.0004
385 ELECTRIC SHOCK SENSATION 1 0.0004
386 SKIN INFECTION 4 0.0004
387 ATYPICAL FEMUR FRACTURE 1 0.0004
388 CEREBRAL THROMBOSIS 1 0.0004
389 HAEMATOCRIT DECREASED 7 0.0004
390 HEPATIC FUNCTION ABNORMAL 13 0.0003
391 SKIN DISCOLOURATION 16 0.0003
392 BLOOD MAGNESIUM DECREASED 3 0.0003
393 SKIN ATROPHY 2 0.0003
394 HERPES VIRUS INFECTION 2 0.0003
395 SKIN SWELLING 3 0.0003
396 PAIN 212 0.0003
397 PRODUCT LABEL CONFUSION 2 0.0003
398 GASTROENTERITIS 5 0.0003
399 NEUROTOXICITY 6 0.0003
400 BONE PAIN 20 0.0003
401 IMMUNOSUPPRESSION 3 0.0003
402 ACUTE RESPIRATORY DISTRESS SYNDROME 6 0.0003
403 PAIN OF SKIN 9 0.0003
404 CHILLS 39 0.0003
405 HIV INFECTION 1 0.0003
406 TOOTHACHE 6 0.0003
407 TENSION 2 0.0003
408 VULVOVAGINAL BURNING SENSATION 2 0.0003
409 FIBROSIS 1 0.0003
410 PROCEDURAL PAIN 9 0.0003
411 MALIGNANT NEOPLASM PROGRESSION 33 0.0003
412 ERYTHEMA MULTIFORME 3 0.0003
413 RASH 140 0.0003
414 BLOOD BLISTER 1 0.0003
415 DELIRIUM 11 0.0003
416 FEBRILE NEUTROPENIA 21 0.0003
417 DISCOMFORT 19 0.0003
418 PAIN IN EXTREMITY 91 0.0003
419 LOWER RESPIRATORY TRACT INFECTION 14 0.0003
420 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
421 VITAMIN D DEFICIENCY 3 0.0003
422 HEPATIC NEOPLASM 1 0.0003
423 PANCYTOPENIA 17 0.0003
424 IMMUNE SYSTEM DISORDER 4 0.0003
425 SKIN MASS 2 0.0003
426 CYTOKINE RELEASE SYNDROME 6 0.0003
427 PERICARDITIS 5 0.0003
428 WRONG PRODUCT ADMINISTERED 2 0.0003
429 MOTOR DYSFUNCTION 3 0.0003
430 EPISTAXIS 22 0.0003
431 MATERNAL EXPOSURE BEFORE PREGNANCY 2 0.0003
432 DECREASED APPETITE 68 0.0003
433 ACUTE HEPATIC FAILURE 4 0.0003
434 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
435 BREAST CANCER 27 0.0003
436 BLOOD CREATININE ABNORMAL 1 0.0003
437 CARDIAC DISORDER 27 0.0003
438 PULMONARY HYPERTENSION 6 0.0003
439 APHONIA 4 0.0003
440 DEFAECATION URGENCY 2 0.0003
441 EAR PRURITUS 1 0.0003
442 ERYTHEMA NODOSUM 1 0.0003
443 OSTEONECROSIS OF JAW 7 0.0003
444 PAIN IN JAW 8 0.0003
445 FIBRIN D DIMER INCREASED 1 0.0003
446 LEUKOPENIA 14 0.0003
447 RED BLOOD CELL COUNT DECREASED 8 0.0003
448 ANGINA PECTORIS 8 0.0003
449 APPARENT DEATH 1 0.0003
450 PARAESTHESIA ORAL 4 0.0003
451 PELVIC PAIN 5 0.0003
452 FAECES SOFT 2 0.0003
453 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
454 C-REACTIVE PROTEIN INCREASED 10 0.0003
455 BLOOD PHOSPHORUS DECREASED 1 0.0003
456 MOUTH HAEMORRHAGE 2 0.0003
457 MELAENA 6 0.0003
458 ILLNESS 28 0.0003
459 HEPATIC CANCER STAGE IV 1 0.0003
460 TRANSAMINASES INCREASED 6 0.0003
461 DYSGEUSIA 20 0.0003
462 MALNUTRITION 3 0.0003
463 CATHETER SITE INFECTION 1 0.0003
464 RHINORRHOEA 17 0.0003
465 MEMORY IMPAIRMENT 36 0.0003
466 MYOCARDITIS 3 0.0003
467 INTERCEPTED PRODUCT ADMINISTRATION ERROR 2 0.0003
468 GINGIVAL DISORDER 1 0.0003
469 ALOPECIA 51 0.0003
470 MADAROSIS 3 0.0003
471 PELVIC FRACTURE 2 0.0003
472 BURNING SENSATION 18 0.0003
473 SWELLING 24 0.0003
474 THERAPY PARTIAL RESPONDER 4 0.0003
475 NERVOUS SYSTEM DISORDER 8 0.0003
476 MALAISE 112 0.0003
477 GASTROINTESTINAL INFLAMMATION 2 0.0003
478 PARAESTHESIA 40 0.0003
479 BACTERAEMIA 3 0.0003
480 BLOOD ALBUMIN DECREASED 2 0.0003
481 EXPOSURE VIA BREAST MILK 1 0.0003
482 HYPERLIPIDAEMIA 3 0.0003
483 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
484 SYNCOPE 25 0.0002
485 DIABETIC KETOACIDOSIS 6 0.0002
486 BLOOD DISORDER 2 0.0002
487 SENSORY DISTURBANCE 4 0.0002
488 RHINITIS 2 0.0002
489 FUNGAL SKIN INFECTION 1 0.0002
490 MUSCLE DISORDER 2 0.0002
491 APPLICATION SITE DISCOLOURATION 1 0.0002
492 GASTROINTESTINAL DISORDER 22 0.0002
493 GOITRE 1 0.0002
494 EXTRAVASATION 1 0.0002
495 INJECTION SITE EXTRAVASATION 3 0.0002
496 ANAPHYLACTOID REACTION 1 0.0002
497 PRURITUS 93 0.0002
498 ILEUS 3 0.0002
499 SKIN DISORDER 8 0.0002
500 DYSSTASIA 7 0.0002
501 DYSPNOEA EXERTIONAL 9 0.0002
502 BLOOD UREA INCREASED 4 0.0002
503 DERMATITIS 5 0.0002
504 DERMATITIS ALLERGIC 3 0.0002
505 HYPOKALAEMIA 11 0.0002
506 BRAIN OEDEMA 3 0.0002
507 HYPERPYREXIA 1 0.0002
508 AORTIC VALVE INCOMPETENCE 1 0.0002
509 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
510 EATING DISORDER 5 0.0002
511 CARDIAC FAILURE CHRONIC 1 0.0002
512 WHITE BLOOD CELL COUNT INCREASED 9 0.0002
513 ANAPHYLACTIC SHOCK 6 0.0002
514 PYELONEPHRITIS 2 0.0002
515 CHAPPED LIPS 1 0.0002
516 BONE CANCER 1 0.0002
517 BLOOD CREATININE INCREASED 15 0.0002
518 URINE OUTPUT DECREASED 2 0.0002
519 DIVERTICULUM INTESTINAL 1 0.0002
520 GROIN PAIN 2 0.0002
521 ABDOMINAL ABSCESS 1 0.0002
522 INJECTION SITE ERYTHEMA 28 0.0002
523 STEVENS-JOHNSON SYNDROME 5 0.0002
524 LUNG DISORDER 11 0.0002
525 CARDIAC FAILURE 18 0.0002
526 THROMBOCYTOPENIA 25 0.0002
527 GASTROINTESTINAL INFECTION 2 0.0002
528 HEAVY MENSTRUAL BLEEDING 2 0.0002
529 NEUTROPHIL COUNT DECREASED 9 0.0002
530 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
531 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
532 GINGIVAL BLEEDING 3 0.0002
533 BONE DISORDER 4 0.0002
534 DISEASE COMPLICATION 1 0.0002
535 IMMUNE THROMBOCYTOPENIA 1 0.0002
536 EAR DISORDER 1 0.0002
537 PNEUMONIA BACTERIAL 2 0.0002
538 DYSPAREUNIA 1 0.0002
539 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
540 EYE OPERATION 1 0.0002
541 IRON DEFICIENCY ANAEMIA 2 0.0002
542 FEELING COLD 6 0.0002
543 AGRANULOCYTOSIS 4 0.0002
544 BACTERIAL INFECTION 4 0.0002
545 PERIPHERAL SWELLING 33 0.0002
546 BLOOD TEST ABNORMAL 3 0.0002
547 BLOOD SODIUM DECREASED 4 0.0002
548 LEUKAEMIA 2 0.0002
549 NASOPHARYNGITIS 39 0.0002
550 FRACTURE 4 0.0002
551 VOMITING 99 0.0002
552 HAEMATOTOXICITY 2 0.0002
553 DEHYDRATION 28 0.0002
554 ENDOMETRIOSIS 1 0.0002
555 FATIGUE 163 0.0002
556 ACUTE KIDNEY INJURY 32 0.0002
557 INJECTION SITE SWELLING 16 0.0002
558 LETHARGY 12 0.0002
559 HEPATIC CANCER 5 0.0002
560 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
561 KIDNEY INFECTION 4 0.0002
562 HEPATOMEGALY 2 0.0002
563 HYPERVOLAEMIA 1 0.0002
564 PULMONARY MASS 3 0.0002
565 PULMONARY OEDEMA 9 0.0002
566 PNEUMONIA 65 0.0002
567 ERYSIPELAS 1 0.0002
568 LACRIMATION INCREASED 6 0.0002
569 DYSPHORIA 1 0.0002
570 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
571 CORONARY ARTERIAL STENT INSERTION 1 0.0002
572 TOOTH ABSCESS 2 0.0002
573 BODY TEMPERATURE INCREASED 4 0.0002
574 HYPONATRAEMIA 11 0.0002
575 FEMORAL NECK FRACTURE 1 0.0002
576 INITIAL INSOMNIA 2 0.0002
577 PRODUCT PREPARATION ERROR 4 0.0002
578 DRUG RESISTANCE 5 0.0002
579 HYPOTENSION 39 0.0002
580 SKIN ULCER 5 0.0002
581 TENDERNESS 2 0.0002
582 JOINT STIFFNESS 5 0.0002
583 DEATH 164 0.0002
584 DYSURIA 7 0.0002
585 GASTRITIS 5 0.0002
586 WEIGHT DECREASED 53 0.0002
587 BLOOD LACTIC ACID INCREASED 1 0.0002
588 INCONTINENCE 2 0.0002
589 ANORECTAL DISCOMFORT 1 0.0002
590 ANAL FISTULA 1 0.0002
591 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
592 COMPRESSION FRACTURE 1 0.0002
593 HIP FRACTURE 6 0.0002
594 LIVER FUNCTION TEST INCREASED 4 0.0002
595 RECTAL HAEMORRHAGE 8 0.0002
596 ANAL ABSCESS 1 0.0002
597 GINGIVITIS 1 0.0002
598 LACTIC ACIDOSIS 6 0.0002
599 BEHAVIOUR DISORDER 1 0.0002
600 HIP SURGERY 1 0.0002
601 ACNE 14 0.0002
602 HYDROCEPHALUS 1 0.0002
603 COUGH 51 0.0002
604 GASTROINTESTINAL PAIN 2 0.0002
605 PHOTOSENSITIVITY REACTION 3 0.0002
606 RESPIRATORY DISTRESS 5 0.0002
607 GASTRIC ULCER HAEMORRHAGE 1 0.0002
608 ACUTE PULMONARY OEDEMA 1 0.0002
609 OXYGEN SATURATION DECREASED 10 0.0002
610 HYPERSENSITIVITY 33 0.0002
611 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
612 EYE INFECTION 2 0.0002
613 MITRAL VALVE INCOMPETENCE 2 0.0002
614 PRODUCT DOSE OMISSION IN ERROR 5 0.0002
615 CIRCULATORY COLLAPSE 3 0.0002
616 SCAB 2 0.0002
617 CARDIAC VALVE DISEASE 1 0.0002
618 GASTRIC HAEMORRHAGE 2 0.0002
619 ELECTROLYTE IMBALANCE 2 0.0002
620 VASCULITIS 2 0.0002
621 HYPOVOLAEMIA 1 0.0002
622 HYPERTRIGLYCERIDAEMIA 1 0.0002
623 ARTHRALGIA 71 0.0002
624 SPINAL PAIN 2 0.0002
625 HYPOXIA 6 0.0002
626 URINARY TRACT INFECTION 29 0.0002
627 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
628 ASPARTATE AMINOTRANSFERASE INCREASED 9 0.0002
629 NEUTROPENIA 23 0.0002
630 ARRHYTHMIA 8 0.0002
631 MUSCLE SPASMS 31 0.0002
632 BLOOD IRON DECREASED 2 0.0002
633 ENDOPHTHALMITIS 1 0.0002
634 OEDEMA 9 0.0002
635 PRESYNCOPE 4 0.0002
636 DYSPEPSIA 16 0.0002
637 HYPOACUSIS 7 0.0002
638 INTERCEPTED PRODUCT PREPARATION ERROR 2 0.0002
639 PALPITATIONS 19 0.0002
640 OROPHARYNGEAL PAIN 15 0.0002
641 MEDICATION ERROR 9 0.0002
642 CHOLANGITIS 1 0.0002
643 TOOTH EXTRACTION 2 0.0002
644 HOT FLUSH 12 0.0002
645 CELLULITIS 8 0.0002
646 LIVER DISORDER 7 0.0002
647 HEPATITIS 4 0.0002
648 SEIZURE 18 0.0002
649 CONTUSION 15 0.0002
650 THERAPY NON-RESPONDER 7 0.0002
651 MOVEMENT DISORDER 5 0.0002
652 DRUG INTOLERANCE 15 0.0002
653 HAEMATOMA 4 0.0002
654 HAEMORRHOIDS 3 0.0002
655 NODULE 2 0.0002
656 APPLICATION SITE ERYTHEMA 4 0.0002
657 INFECTION 22 0.0002
658 SARS-COV-2 TEST POSITIVE 2 0.0002
659 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
660 APPETITE DISORDER 1 0.0002
661 FULL BLOOD COUNT DECREASED 3 0.0001
662 LOSS OF CONSCIOUSNESS 19 0.0001
663 PLEURAL EFFUSION 9 0.0001
664 TACHYPNOEA 2 0.0001
665 CONSTIPATION 32 0.0001
666 ALANINE AMINOTRANSFERASE INCREASED 9 0.0001
667 ECCHYMOSIS 1 0.0001
668 INJECTION SITE WARMTH 3 0.0001
669 ENCEPHALITIS 1 0.0001
670 NAUSEA 114 0.0001
671 AUTOIMMUNE HEPATITIS 1 0.0001
672 EXTRASYSTOLES 1 0.0001
673 RENAL IMPAIRMENT 12 0.0001
674 SLEEP DISORDER 10 0.0001
675 HYPERTENSION 30 0.0001
676 HAND FRACTURE 1 0.0001
677 GAIT DISTURBANCE 27 0.0001
678 DRY EYE 7 0.0001
679 FEAR OF INJECTION 1 0.0001
680 ACCIDENTAL UNDERDOSE 2 0.0001
681 MYELODYSPLASTIC SYNDROME 2 0.0001
682 ANOSMIA 2 0.0001
683 DYSPNOEA 78 0.0001
684 HYPOKINESIA 2 0.0001
685 INTENTIONAL PRODUCT USE ISSUE 12 0.0001
686 DYSPHONIA 8 0.0001
687 RESTLESSNESS 5 0.0001
688 ABDOMINAL PAIN UPPER 28 0.0001
689 ACUTE MYOCARDIAL INFARCTION 4 0.0001
690 BLINDNESS TRANSIENT 1 0.0001
691 BLOOD PRESSURE DECREASED 9 0.0001
692 HEPATOTOXICITY 3 0.0001
693 RESPIRATORY DISORDER 4 0.0001
694 HYDRONEPHROSIS 1 0.0001
695 HEPATOCELLULAR CARCINOMA 1 0.0001
696 ACIDOSIS 1 0.0001
697 FEELING HOT 8 0.0001
698 INJECTION SITE RASH 4 0.0001
699 DEVICE RELATED INFECTION 2 0.0001
700 THYROID DISORDER 2 0.0001
701 LYMPHOMA 2 0.0001
702 BLOOD CHOLESTEROL INCREASED 6 0.0001
703 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
704 ACUTE MYELOID LEUKAEMIA 2 0.0001
705 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
706 ANAPHYLACTIC REACTION 7 0.0001
707 COMA 6 0.0001
708 ANAEMIA 24 0.0001
709 RASH ERYTHEMATOUS 6 0.0001
710 BLOOD PRESSURE FLUCTUATION 3 0.0001
711 DIZZINESS 62 0.0001
712 LOCALISED INFECTION 3 0.0001
713 FRUSTRATION TOLERANCE DECREASED 1 0.0001
714 NEURALGIA 3 0.0001
715 ATRIAL FIBRILLATION 12 0.0001
716 BLOOD POTASSIUM INCREASED 2 0.0001
717 BLINDNESS 5 0.0001
718 ASPHYXIA 1 0.0001
719 INJECTION SITE URTICARIA 3 0.0001
720 LIVER INJURY 3 0.0001
721 HERPES ZOSTER 7 0.0001
722 OSTEONECROSIS 4 0.0001
723 HAIR DISORDER 1 0.0001
724 VENTRICULAR TACHYCARDIA 2 0.0001
725 GENERAL PHYSICAL HEALTH DETERIORATION 14 0.0001
726 ACUTE CORONARY SYNDROME 1 0.0001
727 BACK PAIN 28 0.0001
728 RENAL FAILURE 16 0.0001
729 EMBOLISM 1 0.0001
730 EOSINOPHIL COUNT INCREASED 1 0.0001
731 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
732 SKIN EXFOLIATION 10 0.0001
733 FLUID RETENTION 6 0.0001
734 SEPTIC SHOCK 5 0.0001
735 AMENORRHOEA 2 0.0001
736 BLOOD CALCIUM INCREASED 1 0.0001
737 BRADYCARDIA 6 0.0001
738 INSOMNIA 30 0.0001
739 TACHYCARDIA 10 0.0001
740 ISCHAEMIC STROKE 2 0.0001
741 GOUT 2 0.0001
742 THROAT IRRITATION 5 0.0001
743 FREQUENT BOWEL MOVEMENTS 3 0.0001
744 SKIN LESION 3 0.0001
745 CARDIAC ARREST 9 0.0001
746 FLUSHING 11 0.0001
747 CONJUNCTIVITIS 2 0.0001
748 INFLUENZA 12 0.0001
749 AMNESIA 7 0.0001
750 SEPSIS 12 0.0001
751 ABDOMINAL PAIN 25 0.0001
752 CHEST DISCOMFORT 11 0.0001
753 HEPATIC STEATOSIS 2 0.0001
754 COGNITIVE DISORDER 5 0.0001
755 APPENDICITIS 1 0.0001
756 DIARRHOEA HAEMORRHAGIC 1 0.0001
757 BLISTER 6 0.0001
758 ARTERIOSCLEROSIS 1 0.0001
759 FLATULENCE 6 0.0001
760 HYPOCALCAEMIA 2 0.0001
761 DYSPHAGIA 10 0.0001
762 BLOOD URINE PRESENT 2 0.0001
763 GASTRIC ULCER 2 0.0001
764 ATELECTASIS 1 0.0001
765 LIVER FUNCTION TEST ABNORMAL 3 0.0001
766 NEEDLE ISSUE 3 0.0001
767 EAR PAIN 2 0.0001
768 HEPATIC ENZYME INCREASED 7 0.0001
769 COELIAC DISEASE 1 0.0001
770 INCORRECT DOSE ADMINISTERED 23 0.0001
771 BLADDER DISORDER 1 0.0001
772 UPPER LIMB FRACTURE 2 0.0001
773 BRAIN INJURY 1 0.0001
774 HEPATIC FAILURE 3 0.0001
775 GASTROOESOPHAGEAL REFLUX DISEASE 8 0.0001
776 VERTIGO 6 0.0001
777 EYELID PTOSIS 1 0.0001
778 MOBILITY DECREASED 7 0.0001
779 LIMB DISCOMFORT 3 0.0001
780 DEPRESSION 22 0.0001
781 HYPERBILIRUBINAEMIA 1 0.0001
782 RESPIRATORY FAILURE 7 0.0001
783 ECZEMA 5 0.0001
784 SPEECH DISORDER 5 0.0001
785 MIGRAINE 9 0.0001
786 MOOD SWINGS 3 0.0001
787 HYPOTHYROIDISM 3 0.0001
788 IRRITABLE BOWEL SYNDROME 2 0.0001
789 DECREASED ACTIVITY 1 0.0001
790 DEEP VEIN THROMBOSIS 6 0.0001
791 RASH PRURITIC 5 0.0001
792 SWELLING FACE 6 0.0001
793 MENTAL DISORDER 4 0.0001
794 BLOOD PRESSURE INCREASED 14 0.0001
795 COVID-19 16 0.0001
796 HAEMATOCHEZIA 5 0.0001
797 TOOTH DISORDER 2 0.0001
798 RASH MACULO-PAPULAR 2 0.0001
799 DRY SKIN 12 0.0001
800 HYPERTENSIVE CRISIS 1 0.0001
801 SOMNOLENCE 18 0.0001
802 SNEEZING 2 0.0001
803 BLOOD CALCIUM DECREASED 1 0.0001
804 HEART RATE IRREGULAR 2 0.0001
805 MUSCULAR WEAKNESS 10 0.0001
806 IMPAIRED DRIVING ABILITY 1 0.0001
807 SHOCK 2 0.0001
808 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
809 CHEST PAIN 16 0.0001
810 ABDOMINAL DISTENSION 9 0.0001
811 EYELID OEDEMA 1 0.0001
812 COVID-19 PNEUMONIA 1 0.0001
813 OCULAR HYPERAEMIA 4 0.0001
814 CHOLECYSTITIS 1 0.0001
815 ACCIDENT 1 0.0001
816 ABDOMINAL DISCOMFORT 14 0.0001
817 CEREBROVASCULAR ACCIDENT 14 0.0001
818 MENTAL IMPAIRMENT 2 0.0001
819 BURSITIS 1 0.0001
820 ADRENAL INSUFFICIENCY 1 0.0001
821 CYTOPENIA 1 0.0001
822 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
823 GENERALISED OEDEMA 1 0.0001
824 HEART RATE INCREASED 8 0.0001
825 VISUAL IMPAIRMENT 10 0.0001
826 EYE SWELLING 3 0.0001
827 CYST 1 0.0001
828 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
829 PNEUMONIA ASPIRATION 2 0.0001
830 HEADACHE 50 0.0001
831 ABDOMINAL PAIN LOWER 2 0.0001
832 GASTRIC CANCER 2 0.0001
833 PRODUCT COMPLAINT 2 0.0001
834 HAEMATEMESIS 2 0.0001
835 INJECTION SITE IRRITATION 1 0.0001
836 INFUSION SITE PAIN 1 0.0001
837 INFLAMMATION 4 0.0001
838 DIPLOPIA 2 0.0001
839 RESPIRATORY TRACT INFECTION 2 0.0001
840 WEIGHT INCREASED 17 0.0001
841 DISORIENTATION 3 0.0001
842 DEPRESSED MOOD 4 0.0001
843 ADVERSE REACTION 1 0.0001
844 EYE HAEMORRHAGE 1 0.0001
845 HAIR TEXTURE ABNORMAL 1 0.0001
846 JAUNDICE 2 0.0001
847 EXTRA DOSE ADMINISTERED 3 0.0001
848 DRY MOUTH 6 0.0001
849 THROAT TIGHTNESS 2 0.0001
850 LIMB INJURY 2 0.0001
851 PALLOR 2 0.0001
852 POLLAKIURIA 3 0.0001
853 HYPOMAGNESAEMIA 1 0.0001
854 CARDIO-RESPIRATORY ARREST 3 0.0001
855 COORDINATION ABNORMAL 1 0.0001
856 URTICARIA 12 0.0001
857 WOUND 2 0.0001
858 DRUG INEFFECTIVE 94 0.0001
859 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
860 FEELING ABNORMAL 17 0.0001
861 BLINDNESS UNILATERAL 1 0.0001
862 CARDIOGENIC SHOCK 1 0.0001
863 VAGINAL HAEMORRHAGE 3 0.0001
864 FALL 23 0.0001
865 INJECTION SITE HAEMATOMA 1 0.0001
866 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
867 APATHY 1 0.0001
868 LABORATORY TEST ABNORMAL 2 0.0001
869 MATERNAL EXPOSURE DURING PREGNANCY 6 0.0001
870 ANXIETY 19 0.0001
871 JOINT SWELLING 8 0.0001
872 CORONARY ARTERY DISEASE 2 0.0001
873 DEVICE FAILURE 1 0.0001
874 OEDEMA PERIPHERAL 8 0.0001
875 DIABETES MELLITUS 5 0.0001
876 VISION BLURRED 9 0.0001
877 HIP ARTHROPLASTY 1 0.0001
878 ANKLE FRACTURE 1 0.0001
879 RENAL DISORDER 3 0.0001
880 DRUG-INDUCED LIVER INJURY 2 0.0001
881 BLOOD GLUCOSE INCREASED 12 0.0001
882 CYANOSIS 1 0.0001
883 PULMONARY EMBOLISM 6 0.0001
884 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
885 DISEASE RECURRENCE 3 0.0001
886 PRODUCTIVE COUGH 3 0.0001
887 ABSCESS 1 0.0001
888 CONDITION AGGRAVATED 19 0.0001
889 NIGHT SWEATS 2 0.0001
890 EYE DISORDER 2 0.0001
891 INFLUENZA LIKE ILLNESS 5 0.0001
892 STAPHYLOCOCCAL INFECTION 2 0.0001
893 COAGULOPATHY 1 0.0001
894 FACE OEDEMA 1 0.0001
895 HEMIPARESIS 1 0.0001
896 SINUSITIS 6 0.0001
897 HAEMATURIA 2 0.0001
898 BALANCE DISORDER 5 0.0001
899 RASH MACULAR 2 0.0001
900 MUSCULOSKELETAL STIFFNESS 5 0.0001
901 DRUG ERUPTION 1 0.0001
902 SKIN BURNING SENSATION 4 0.0001
903 GASTROENTERITIS VIRAL 1 0.0001
904 PANIC ATTACK 2 0.0001
905 ACCIDENTAL OVERDOSE 2 0.0001
906 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 11 0.0001
907 HEPATIC CIRRHOSIS 1 0.0001
908 FOOT FRACTURE 1 0.0001
909 CHRONIC KIDNEY DISEASE 4 0.0001
910 ACUTE RESPIRATORY FAILURE 1 0.0001
911 GLAUCOMA 1 0.0001
912 HERNIA 1 0.0001
913 MYOCARDIAL INFARCTION 9 0.0001
914 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
915 NASAL CONGESTION 3 0.0001
916 DISABILITY 1 0.0001
917 CATARACT 3 0.0001
918 ABORTION SPONTANEOUS 2 0.0000
919 IRRITABILITY 3 0.0000
920 THROMBOSIS 4 0.0000
921 LUNG NEOPLASM MALIGNANT 2 0.0000
922 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
923 TREMOR 8 0.0000
924 PRODUCT USE ISSUE 9 0.0000
925 HAEMORRHAGE 5 0.0000
926 TOXICITY TO VARIOUS AGENTS 8 0.0000
927 IMPAIRED WORK ABILITY 1 0.0000
928 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
929 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
930 APPLICATION SITE PAIN 1 0.0000
931 SKIN IRRITATION 2 0.0000
932 CONFUSIONAL STATE 7 0.0000
933 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
934 DEVICE MALFUNCTION 3 0.0000
935 MULTIPLE SCLEROSIS 2 0.0000
936 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
937 CEREBRAL INFARCTION 1 0.0000
938 BRONCHITIS 3 0.0000
939 CARDIOVASCULAR DISORDER 1 0.0000
940 THERAPY CESSATION 2 0.0000
941 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 7 0.0000
942 HYPERHIDROSIS 5 0.0000
943 EXPOSURE VIA SKIN CONTACT 1 0.0000
944 INJECTION SITE BRUISING 3 0.0000
945 INJECTION SITE HAEMORRHAGE 3 0.0000
946 PRODUCT DOSE OMISSION ISSUE 11 0.0000
947 FEAR 1 0.0000
948 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
949 ABNORMAL DREAMS 1 0.0000
950 DIVERTICULITIS 1 0.0000
951 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
952 NECK PAIN 2 0.0000
953 DEMENTIA 1 0.0000
954 EYE PAIN 2 0.0000
955 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
956 ASCITES 1 0.0000
957 WHEEZING 2 0.0000
958 ADVERSE DRUG REACTION 3 0.0000
959 APHASIA 1 0.0000
960 THERAPEUTIC RESPONSE DECREASED 2 0.0000
961 FEMUR FRACTURE 1 0.0000
962 HEAD INJURY 1 0.0000
963 CYSTITIS 1 0.0000
964 PSORIASIS 4 0.0000
965 FUNGAL INFECTION 1 0.0000
966 ANGER 1 0.0000
967 GASTRIC DISORDER 1 0.0000
968 HYPERKALAEMIA 1 0.0000
969 HEART RATE DECREASED 1 0.0000
970 INJURY 2 0.0000
971 THERAPY INTERRUPTED 2 0.0000
972 CEREBRAL HAEMORRHAGE 1 0.0000
973 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
974 CRYING 1 0.0000
975 UNDERDOSE 2 0.0000
976 INJECTION SITE MASS 1 0.0000
977 DYSARTHRIA 1 0.0000
978 HOSPITALISATION 4 0.0000
979 DEVICE BREAKAGE 1 0.0000
980 OVERDOSE 5 0.0000
981 DEVICE ISSUE 2 0.0000
982 BLOOD GLUCOSE DECREASED 1 0.0000
983 HYPOGLYCAEMIA 1 0.0000
984 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
985 DISTURBANCE IN ATTENTION 1 0.0000
986 ARTHROPATHY 1 0.0000
987 EYE IRRITATION 1 0.0000
988 PRODUCT QUALITY ISSUE 2 0.0000
989 HALLUCINATION 1 0.0000
990 DRUG INTERACTION 2 0.0000
991 CARDIAC FAILURE CONGESTIVE 1 0.0000
992 COMPLETED SUICIDE 1 0.0000
993 ASTHMA 1 0.0000
994 EMOTIONAL DISTRESS 1 0.0000